APLT
Applied Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Applied Therapeutics (APLT) Stock: Buy, Sell, or Hold?
$0.10
+0.00 (+0.19%)
â˛
5d:
+6.96%
30d:
+3.0%
90d:
-90.88%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (82%)
Quality Score
49/100
Position
FAIR
Forward P/E & Valuation
-0.3x
Next 12M consensus est.
Wall Street Target
$0.25
+142.7% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.09 / $0.11
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: APLT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When APLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: APLT is currently trading at $0.10, which is considered fair based on recent price action.
Technical Outlook: Technically, APLT is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $0.11.
Market Sentiment: APLT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $0.25 (+142.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APLT is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $0.11.
Market Sentiment: APLT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $0.25 (+142.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
Trading Range & Key Levels
Support Level
$0.09
Resistance Level
$0.11
Current Trend
Strong Uptrend
Technical data as of
Feb 2, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 142.7% below Wall St target ($0.25)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.26
Wall Street Target
$0.25
(+142.7%)
Revenue Growth (YoY)
719.7%
Share APLT Analysis
Share this live APLT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (APLT)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Feb 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment on $APLT increased due to a StockTwits message expressing concern about a lack of SEC filing and potential chapter 11 bankruptcy.
Key Retail Themes:
SEC filing concerns
Bankruptcy rumors
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:51 AM ET
Data refreshes hourly during market hours. Next update: 4:51 AM
Data refreshes hourly during market hours. Next update: 4:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive APLT Research Pages
